Home
News
Create
Screeners
Insights
Lincoln Pharmaceuticals
482.
25
+3.50
(+0.73%)
Market Cap
₹965.93 Cr
PE Ratio
11.95
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.73%
1M
+1.99%
6M
-12.29%
1Y
-37.19%
5Y
+103.48%
View Company Insights
Latest news about Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Receives CRISIL Credit Rating Reaffirmation at A/Stable for Long-term Facilities
4 days ago
Lincoln Pharmaceuticals Limited received credit rating reaffirmation from CRISIL Limited on January 09, 2026, with long-term bank facilities maintained at CRISIL A/Stable and short-term facilities at CRISIL A1. The ratings cover total bank facilities of ₹102.00 crore and reflect the company's established market position, promoter experience, and healthy financial profile with ₹671.00 crore networth against nil debt. Revenue grew 14.00% to ₹623.23 crore in fiscal 2025, though working capital intensity and regulatory risks remain areas of concern.
Lincoln Pharmaceuticals Reports 16.93% Profit Growth in Q1, Reappoints Key Directors
Aug 07, 2025
Lincoln Pharma Reports 17% Net Profit Growth in Q1, Targets ₹1,000 Crore Revenue in 3 Years
Aug 07, 2025
Lincoln Pharmaceuticals Completes Trial Run at Khatraj Facility, Eyes API Production
Jul 02, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation